Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;18(4):32.
doi: 10.1007/s11906-016-0639-4.

Pharmacologic Treatment of Pediatric Hypertension

Rachita S Dhull  1 , Rossana Baracco  1 , Amrish Jain  1 , Tej K Mattoo  2
Affiliations
Review

Pharmacologic Treatment of Pediatric Hypertension

Rachita S Dhull et al. Curr Hypertens Rep. 2016 Apr.

Abstract

Prevalence of hypertension is increasing in children and adolescents. Uncontrolled hypertension in children not only causes end organ damage but also increases the risk of adult hypertension and cardiovascular disease. Clinical trials have proven efficacy of antihypertensive medications in children. These medications are well tolerated by children with acceptable safety profile. The choice of agent is usually driven by underlying etiology of hypertension, profile of its side effects, and clinician's preference. This article will review currently available pediatric data on mechanism of action, common adverse effects, pediatric indication, recent clinical trial, and newer drugs in the common classes of antihypertensive medications.

Keywords: Clinical trials; Dosing for hypertension; Hypertension; Hypertension in children; Pharmacologic management.

PubMed Disclaimer

References

    1. Expert Opin Drug Saf. 2002 May;1(1):39-43 - PubMed
    1. Clin J Am Soc Nephrol. 2010 Mar;5(3):417-24 - PubMed
    1. Hypertension. 2010 Jun;55(6):1323-30 - PubMed
    1. N Engl J Med. 2009 Oct 22;361(17):1639-50 - PubMed
    1. Am Heart J. 2006 Aug;152(2):394-9 - PubMed

MeSH terms

LinkOut - more resources